Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 375

1.

Rendezvous technique assisted by anchor device: a new trick for endoscopic treatment of fistulas in the digestive tract.

Abecia V, Mahler MA, Duran S, Manazzoni D, Pizzala J, Villa-Gómez Roig G, Marcolongo M.

Endoscopy. 2020 Mar 27. doi: 10.1055/a-1125-5703. [Epub ahead of print] No abstract available.

PMID:
32219783
2.

Curative-Intent Therapies in Localized Hepatocellular Carcinoma.

O'Leary C, Mahler M, Soulen MC.

Curr Treat Options Oncol. 2020 Mar 19;21(4):31. doi: 10.1007/s11864-020-0725-3. Review.

PMID:
32193784
3.

Precision medicine in the care of rheumatoid arthritis: Focus on prediction and prevention of future clinically-apparent disease.

Mahler M, Martinez-Prat L, Sparks JA, Deane KD.

Autoimmun Rev. 2020 Mar 12:102506. doi: 10.1016/j.autrev.2020.102506. [Epub ahead of print] Review.

PMID:
32173516
4.

A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus.

Choi MY, FitzPatrick RD, Buhler K, Mahler M, Fritzler MJ.

Autoimmun Rev. 2020 Mar;19(3):102463. doi: 10.1016/j.autrev.2020.102463. Epub 2020 Jan 9.

5.

IgA Antibodies Directed Against Citrullinated Protein Antigens Are Elevated in Patients With Idiopathic Pulmonary Fibrosis.

Solomon JJ, Matson S, Kelmenson LB, Chung JH, Hobbs SB, Rosas IO, Dellaripa PF, Doyle TJ, Poli S, Esposito AJ, Visser A, Marin AI, Amigues I, Fernández Pérez ER, Brown KK, Mahler M, Heinz D, Cool C, Deane KD, Swigris JJ, Demoruelle MK.

Chest. 2019 Dec 23. pii: S0012-3692(19)34454-X. doi: 10.1016/j.chest.2019.12.005. [Epub ahead of print]

PMID:
31877269
6.

Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs.

de Moel EC, Rech J, Mahler M, Roth J, Vogl T, Schouffoer A, Goekoop RJ, Huizinga TWJ, Allaart CF, Toes REM, Schett G, van der Woude D.

Arthritis Res Ther. 2019 Dec 5;21(1):268. doi: 10.1186/s13075-019-2064-y.

7.

Anti-Ku antibodies: important points to consider.

Mahler M, Satoh M, Fritzler MJ.

Ann Rheum Dis. 2019 Nov 20. pii: annrheumdis-2019-216535. doi: 10.1136/annrheumdis-2019-216535. [Epub ahead of print] No abstract available.

PMID:
31748234
8.

Autoantibodies to protein-arginine deiminase (PAD) 4 in rheumatoid arthritis: immunological and clinical significance, and potential for precision medicine.

Martinez-Prat L, Palterer B, Vitiello G, Parronchi P, Robinson WH, Mahler M.

Expert Rev Clin Immunol. 2019 Oct;15(10):1073-1087. doi: 10.1080/1744666X.2020.1668778. Epub 2019 Oct 13.

PMID:
31524005
9.

Harmonization of clinical interpretation of antinuclear antibody test results by solid phase assay and by indirect immunofluorescence through likelihood ratios.

Bossuyt X, Claessens J, Belmondo T, De Langhe E, Westhovens R, Poesen K, Hüe S, Blockmans D, Fritzler MJ, Mahler M, Fierz W.

Autoimmun Rev. 2019 Nov;18(11):102386. doi: 10.1016/j.autrev.2019.102386. Epub 2019 Sep 11. No abstract available.

PMID:
31520795
10.

Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia.

Kipps TJ, Fraser G, Coutre SE, Brown JR, Barrientos JC, Barr PM, Byrd JC, O'Brien SM, Dilhuydy MS, Hillmen P, Jaeger U, Moreno C, Cramer P, Stilgenbauer S, Chanan-Khan AA, Mahler M, Salman M, Eckert K, Solman IG, Balasubramanian S, Cheng M, Londhe A, Ninomoto J, Howes A, James DF, Hallek M.

Clin Lymphoma Myeloma Leuk. 2019 Nov;19(11):715-722.e6. doi: 10.1016/j.clml.2019.07.004. Epub 2019 Jul 15.

11.

Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies.

Cavazzana I, Richards M, Bentow C, Seaman A, Fredi M, Giudizi MG, Palterer B, Pratesi F, Migliorini P, Franceschini F, Satoh M, Ceribelli A, Mahler M.

J Immunol Methods. 2019 Nov;474:112661. doi: 10.1016/j.jim.2019.112661. Epub 2019 Aug 21.

12.

Two Novel Technologies for the Detection of Anti-cardiolipin and Anti β2-Glycoprotein Antibodies in the Real Life: Chemiluminescent in Comparison to the Addressable Laser Bead Immunoassays.

Grossi V, Infantino M, Benucci M, Li Gobbi F, Bandinelli F, Damiani A, Bodio C, Borghi MO, Mahler M, Aure MA, Bentow C, Manfredi M.

Immunol Invest. 2020 Feb;49(1-2):58-68. doi: 10.1080/08820139.2019.1647233. Epub 2019 Aug 12.

PMID:
31401900
13.

Standardisation of myositis-specific antibodies: where are we today?

Mahler M, Vulsteke JB, Bossuyt X, De Langhe E, Satoh M.

Ann Rheum Dis. 2019 Aug 3. pii: annrheumdis-2019-216003. doi: 10.1136/annrheumdis-2019-216003. [Epub ahead of print] No abstract available.

PMID:
31377729
14.

Augmented versus artificial intelligence for stratification of patients with myositis.

Mahler M, Rossin B, Kubassova O.

Ann Rheum Dis. 2019 Jul 30. pii: annrheumdis-2019-216000. doi: 10.1136/annrheumdis-2019-216000. [Epub ahead of print] No abstract available.

PMID:
31362996
15.

Autoantibodies to a novel Rpp38 (Th/To) derived B-cell epitope are specific for systemic sclerosis and associate with a distinct clinical phenotype.

Koenig M, Bentow C, Satoh M, Fritzler MJ, Senécal JL, Mahler M.

Rheumatology (Oxford). 2019 Oct 1;58(10):1784-1793. doi: 10.1093/rheumatology/kez123.

PMID:
31323671
16.

Only monospecific anti-DFS70 antibodies aid in the exclusion of antinuclear antibody associated rheumatic diseases: an Italian experience.

Infantino M, Pregnolato F, Bentow C, Mahler M, Benucci M, Li Gobbi F, Damiani A, Grossi V, Franceschini F, Bodio C, Borghi MO, Manfredi M.

Clin Chem Lab Med. 2019 Oct 25;57(11):1764-1769. doi: 10.1515/cclm-2019-0454.

PMID:
31318689
17.

Comparison of Cellular Death Pathways after mTHPC-mediated Photodynamic Therapy (PDT) in Five Human Cancer Cell Lines.

Lange C, Lehmann C, Mahler M, Bednarski PJ.

Cancers (Basel). 2019 May 21;11(5). pii: E702. doi: 10.3390/cancers11050702.

18.

Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies.

Mahler M, Betteridge Z, Bentow C, Richards M, Seaman A, Chinoy H, McHugh N.

Front Immunol. 2019 Apr 30;10:848. doi: 10.3389/fimmu.2019.00848. eCollection 2019.

19.

Antinuclear antibodies by indirect immunofluorescence and solid phase assays.

Bossuyt X, Claessens J, De Langhe E, Belmondo T, Westhovens R, Hue S, Poesen K, Blockmans D, Mahler M, Fritzler MJ.

Ann Rheum Dis. 2019 May 10. pii: annrheumdis-2019-215443. doi: 10.1136/annrheumdis-2019-215443. [Epub ahead of print] No abstract available.

PMID:
31076390
20.

Anti-OJ autoantibodies: Rare or underdetected?

Vulsteke JB, Satoh M, Malyavantham K, Bossuyt X, De Langhe E, Mahler M.

Autoimmun Rev. 2019 Jul;18(7):658-664. doi: 10.1016/j.autrev.2019.05.002. Epub 2019 May 3. Review.

PMID:
31059843
21.

Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial.

Lavezzi SM, de Jong J, Neyens M, Cramer P, Demirkan F, Fraser G, Bartlett N, Dilhuydy MS, Loscertales J, Avigdor A, Rule S, Samoilova O, Goy A, Ganguly S, Salman M, Howes A, Mahler M, De Nicolao G, Poggesi I.

Pharm Res. 2019 May 1;36(7):93. doi: 10.1007/s11095-019-2605-8.

PMID:
31044267
22.

Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis.

Amlani A, Choi MY, Tarnopolsky M, Brady L, Clarke AE, Garcia-De La Torre I, Mahler M, Schmeling H, Barber CE, Jung M, Fritzler MJ.

Front Immunol. 2019 Apr 9;10:745. doi: 10.3389/fimmu.2019.00745. eCollection 2019.

23.

The Prevalence of Anti-Hexokinase-1 and Anti-Kelch-Like 12 Peptide Antibodies in Patients With Primary Biliary Cholangitis Is Similar in Europe and North America: A Large International, Multi-Center Study.

Norman GL, Reig A, Viñas O, Mahler M, Wunsch E, Milkiewicz P, Swain MG, Mason A, Stinton LM, Aparicio MB, Aldegunde MJ, Fritzler MJ, Parés A.

Front Immunol. 2019 Apr 3;10:662. doi: 10.3389/fimmu.2019.00662. eCollection 2019.

24.

Anticyclic Citrullinated Peptide Antibodies 3.1 and Anti-CCP-IgA Are Associated with Increasing Age in Individuals Without Rheumatoid Arthritis.

Berens HM, Polinski KJ, Mikuls TR, Khatter S, August J, Visser A, Mahler M, Weisman MH, O'Dell JR, Keating RM, Buckner JH, Gregersen PK, Norris JM, Holers VM, Deane KD, Demoruelle MK.

J Rheumatol. 2019 Dec;46(12):1556-1559. doi: 10.3899/jrheum.180897. Epub 2019 Apr 15.

PMID:
30988128
25.

Autoantibodies to Mi-2 alpha and Mi-2 beta in patients with idiopathic inflammatory myopathy.

Richards M, García-De La Torre I, González-Bello YC, Vázquez-Del Mercado M, Andrade-Ortega L, Medrano-Ramírez G, Navarro-Zarza JE, Maradiaga-Ceceña M, Loyo E, Rojo-Mejía A, Gómez G, Seaman A, Fritzler MJ, Koenig M, Mahler M.

Rheumatology (Oxford). 2019 Sep 1;58(9):1655-1661. doi: 10.1093/rheumatology/kez092. Review.

PMID:
30938432
26.

Autoantibodies at the Center of (sub)Classification-Issues of Detection.

Vulsteke JB, De Langhe E, Mahler M.

JAMA Neurol. 2019 Jul 1;76(7):867-868. doi: 10.1001/jamaneurol.2019.0440. No abstract available.

PMID:
30933251
27.

A systematic mixed methods review: Recovering from a hip fracture in a health promoting perspective.

Lind J, Mahler M.

Nurs Open. 2018 Nov 18;6(2):313-329. doi: 10.1002/nop2.214. eCollection 2019 Apr. Review.

28.

Impact of immigration status on health behaviors and perceptions in cancer survivors.

Liu SY, Lu L, Pringle D, Mahler M, Niu C, Charow R, Tiessen K, Lam C, Halytskyy O, Naik H, Hon H, Irwin M, Pat V, Gonos C, Chan CWT, Villeneuve J, Shani RM, Chaudhry M, Brown MC, Selby P, Howell D, Xu W, Alibhai SMH, Jones JM, Liu G, Eng L.

Cancer Med. 2019 May;8(5):2623-2635. doi: 10.1002/cam4.2079. Epub 2019 Mar 21.

29.

Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study.

Sciascia S, Radin M, Cecchi I, Rubini E, Scotta A, Rolla R, Montaruli B, Pergolini P, Mengozzi G, Muccini E, Baldovino S, Ferro M, Vaccarino A, Mahler M, Menegatti E, Roccatello D.

Front Immunol. 2019 Mar 5;10:376. doi: 10.3389/fimmu.2019.00376. eCollection 2019.

30.

Implications for redefining the dense fine speckled and related indirect immunofluorescence patterns.

Mahler M, Andrade LE, Casiano CA, Malyavantham K, Fritzler MJ.

Expert Rev Clin Immunol. 2019 May;15(5):447-448. doi: 10.1080/1744666X.2019.1596802. Epub 2019 Mar 29. No abstract available.

PMID:
30880500
31.

Interleukin-17/Interleukin-21 and Interferon-γ producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome.

Benagiano M, Borghi MO, Romagnoli J, Mahler M, Bella CD, Grassi A, Capitani N, Emmi G, Troilo A, Silvestri E, Emmi L, Alnwaisri H, Bitetti J, Tapinassi S, Prisco D, Baldari CT, Meroni PL, D'Elios MM.

Haematologica. 2019 Dec;104(12):2519-2527. doi: 10.3324/haematol.2018.209536. Epub 2019 Mar 14.

32.

Increased prevalence of anti-DFS70 antibodies in young females: experience from a large international multi-center study on blood donors.

Albesa R, Sachs U, Infantino M, Manfredi M, Benucci M, Baus Y, Lutterbeck S, Andrade L, Morris K, Friedenberg A, Casas S, Bossuyt X, Mahler M.

Clin Chem Lab Med. 2019 Jun 26;57(7):999-1005. doi: 10.1515/cclm-2018-1233.

PMID:
30739097
33.

Tryptophan-kynurenine profile in pediatric autoimmune hepatitis.

Lytton SD, Osiecki M, MałgorzataWoźniak, Cukrowska B, Wierzbicka A, Goliszek M, Socha P, Janczyk W, Dayanakli D, Abendroth D, Kramp S, Fechner K, Scheper T, Mahler M, Bentow C, Bogdanos D, Fuchs D, Woynarowski M.

Immunol Res. 2019 Feb;67(1):39-47. doi: 10.1007/s12026-019-9068-1.

PMID:
30666511
34.

Clinical Utility of Antipeptidyl Arginine Deiminase Type 4 Antibodies.

Darrah E, Martinez-Prat L, Mahler M.

J Rheumatol. 2019 Mar;46(3):329-330. doi: 10.3899/jrheum.180905. Epub 2019 Jan 15. No abstract available.

PMID:
30647163
35.

Anti-DFS70 antibodies: an update on our current understanding and their clinical usefulness.

Mahler M, Andrade LE, Casiano CA, Malyavantham K, Fritzler MJ.

Expert Rev Clin Immunol. 2019 Mar;15(3):241-250. doi: 10.1080/1744666X.2019.1562903. Epub 2019 Feb 4.

PMID:
30623687
36.

Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis.

Brown JR, Moslehi J, Ewer MS, O'Brien SM, Ghia P, Cymbalista F, Shanafelt TD, Fraser G, Rule S, Coutre SE, Dilhuydy MS, Cramer P, Jaeger U, Dreyling M, Byrd JC, Treon S, Liu EY, Chang S, Bista A, Vempati R, Boornazian L, Valentino R, Reddy V, Mahler M, Yang H, Graef T, Burger JA.

Br J Haematol. 2019 Feb;184(4):558-569. doi: 10.1111/bjh.15690. Epub 2018 Dec 2.

37.

The Utilization of Autoantibodies in Approaches to Precision Health.

Fritzler MJ, Martinez-Prat L, Choi MY, Mahler M.

Front Immunol. 2018 Nov 16;9:2682. doi: 10.3389/fimmu.2018.02682. eCollection 2018.

38.

Diagnostic performance of a new anti-carbamylated protein assay in rheumatic diseases.

Shi J, Milo J, Brady K, Bentow C, Conklin J, O'Malley T, Poling D, Ibarra C, Mahler M, Dervieux T.

Scand J Rheumatol. 2019 May;48(3):249-250. doi: 10.1080/03009742.2018.1530372. Epub 2018 Nov 13. No abstract available.

PMID:
30422725
39.

Patterns, perceptions and their association with changes in alcohol consumption in cancer survivors.

Eng L, Pringle D, Su J, Espin-Garcia O, Niu C, Mahler M, Halytskyy O, Charow R, Lam C, Shani RM, Villeneuve J, Tiessen K, Dobriyal A, Zarrin A, Vennettilli A, Brown MC, Alibhai SMH, Howell D, Jones JM, Selby P, Xu W, Liu G.

Eur J Cancer Care (Engl). 2019 Jan;28(1):e12933. doi: 10.1111/ecc.12933. Epub 2018 Oct 16.

PMID:
30324631
40.

Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma.

Fraser G, Cramer P, Demirkan F, Silva RS, Grosicki S, Pristupa A, Janssens A, Mayer J, Bartlett NL, Dilhuydy MS, Pylypenko H, Loscertales J, Avigdor A, Rule S, Villa D, Samoilova O, Panagiotidis P, Goy A, Pavlovsky MA, Karlsson C, Hallek M, Mahler M, Salman M, Sun S, Phelps C, Balasubramanian S, Howes A, Chanan-Khan A.

Leukemia. 2019 Apr;33(4):969-980. doi: 10.1038/s41375-018-0276-9. Epub 2018 Oct 12.

41.

In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy.

Bergua C, Chiavelli H, Allenbach Y, Arouche-Delaperche L, Arnoult C, Bourdenet G, Jean L, Zoubairi R, Guerout N, Mahler M, Benveniste O, Drouot L, Boyer O.

Ann Rheum Dis. 2019 Jan;78(1):131-139. doi: 10.1136/annrheumdis-2018-213518. Epub 2018 Oct 11.

PMID:
30309969
42.

Antibodies targeting protein-arginine deiminase 4 (PAD4) demonstrate diagnostic value in rheumatoid arthritis.

Martinez-Prat L, Lucia D, Ibarra C, Mahler M, Dervieux T.

Ann Rheum Dis. 2019 Mar;78(3):434-436. doi: 10.1136/annrheumdis-2018-213818. Epub 2018 Oct 8. No abstract available.

PMID:
30297325
43.

Two-Parametric Immunological Score Development for Assessing Renal Involvement and Disease Activity in Systemic Lupus Erythematosus.

Sjöwall C, Bentow C, Aure MA, Mahler M.

J Immunol Res. 2018 Aug 30;2018:1294680. doi: 10.1155/2018/1294680. eCollection 2018.

44.

Laparoscopic cholecystectomy complications: a new case report of a right hepatic artery pseudoaneurysm that caused jaundice.

Villa-Gomez G, Mahler MA, Manazzoni D.

Rev Esp Enferm Dig. 2018 Dec;110(12):832. doi: 10.17235/reed.2018.5668/2018.

45.

Prevalence and significance of anti-phosphatidylserine antibodies: A pooled analysis in 5992 patients.

Radin M, Cecchi I, Rubini E, Schreiber K, Roccatello D, Mahler M, Sciascia S.

Thromb Res. 2018 Oct;170:28-31. doi: 10.1016/j.thromres.2018.07.031. Epub 2018 Aug 2. No abstract available.

PMID:
30096511
46.

Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.

Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin PR, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Manzi S, Nived O, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Stoll T, Buyon J, Mahler M, Fritzler MJ.

Arthritis Care Res (Hoboken). 2019 Jul;71(7):893-902. doi: 10.1002/acr.23712. Epub 2019 Jun 12.

PMID:
30044551
47.

Variation in antinuclear antibody detection: need for clear expectations and additional studies.

Mahler M, Auza C.

Ann Rheum Dis. 2019 Oct;78(10):e118. doi: 10.1136/annrheumdis-2018-213888. Epub 2018 Jun 29. No abstract available.

PMID:
29960978
48.

Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance.

Martinez-Prat L, Nissen MJ, Lamacchia C, Bentow C, Cesana L, Roux-Lombard P, Gabay C, Mahler M.

Front Immunol. 2018 Jun 6;9:1113. doi: 10.3389/fimmu.2018.01113. eCollection 2018.

49.

Redefining systemic lupus erythematosus - SMAARTT proteomics.

Fritzler MJ, Mahler M.

Nat Rev Rheumatol. 2018 Aug;14(8):451-452. doi: 10.1038/s41584-018-0035-3. No abstract available.

PMID:
29907860
50.

Ileal tubular adenoma as a cause of lower gastrointestinal bleeding in infants.

Prieto RG, Mahler MA, Vidales G.

Rev Esp Enferm Dig. 2018 Aug;110(8):532-533. doi: 10.17235/reed.2018.5571/2018.

Supplemental Content

Loading ...
Support Center